In cutaneous melanoma the selective advantage for TERT promoter mutations arises from critically short telomeres, and mutational activation of TERT expression does not result in a net re-extension of telomeres, leaving telomeres short36. The gene discussed is TERT; the disease is cutaneous melanoma.